FindTrial
Sign In

choline magnesium trisalicylate

DRUG3 trials

Sponsors

Rutgers, The State University of New Jersey

Conditions

Adult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)Adult Acute Monoblastic Leukemia (M5a)Adult Acute Monocytic Leukemia (M5b)Adult Acute Myeloblastic Leukemia With Maturation (M2)Adult Acute Myeloblastic Leukemia Without Maturation (M1)Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)

Phase 1

Gene Expression During Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With Choline Magnesium Trisalicylate
TerminatedNCT00156299
Rutgers, The State University of New JerseyLeukemia
Start: 2003-03-31End: 2008-07-31Updated: 2013-11-19

Phase 2

Phase II Study of TPA Plus Dexamethasone & CMT in Hematologic Malignancies
TerminatedNCT01009931
Rutgers, The State University of New JerseyLeukemia
Start: 2011-03-31End: 2014-09-30Updated: 2015-11-04
Choline Magnesium Trisalicylate and Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia
CompletedNCT02144675
Rutgers, The State University of New JerseyAdult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic Leukemia (M5a) +14
Start: 2009-01-31End: 2016-04-26Updated: 2021-08-24